Belarus vs Sudan: Tuberculosis patients living with HIV receiving antiretroviral therapy
Belarus
111 patients
in 2021
Sudan
127 patients
in 2021
Belarus rank
76th
Sudan rank
73rd
Tuberculosis patients living with HIV receiving antiretroviral therapy over time
- Belarus
- Sudan
How they compare
Sudan currently reports 127 patients against 111 patients in Belarus, a difference of 16 patients.
That makes Sudan's figure about 1.1 times Belarus's.
The two have swapped places 6 times across 11 shared years of data; in 2011 it was Sudan ahead.
Belarus ranks 76th and Sudan ranks 73rd of 183 countries.
Across the 2 decades both report, Belarus averaged higher in 1 and Sudan in 1.
Head to head by decade
| Decade | Belarus | Sudan | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 163.89 patients | 158.33 patients | 5.56 patients | Belarus |
| 2020s | 117.5 patients | 118 patients | 0.5 patients | Sudan |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher tuberculosis patients living with hiv receiving antiretroviral therapy, Belarus or Sudan?
- Sudan, at 127 patients against 111 patients in Belarus as of 2021.
- What is the difference in tuberculosis patients living with hiv receiving antiretroviral therapy between Belarus and Sudan?
- 16 patients, with Sudan ahead.
- How many years of comparable data are there for Belarus and Sudan?
- 11 years are reported by both, from 2011 to 2021.
- How do Belarus and Sudan rank globally for tuberculosis patients living with hiv receiving antiretroviral therapy?
- Belarus ranks 76th and Sudan ranks 73rd of 183 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026); Population based on various sources (2024) – with minor processing by Our World in Data, published as Tuberculosis patients living with HIV receiving antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of tuberculosis patients who are living with HIV and receiving antiretroviral therapy.